An adjuvant chemotherapy regimen consisting of docetaxel (Taxotere), doxorubicin hydrochloride (Adriamycin) and cyclophosphamide used for the treatment of breast cancer.
As scientists who evolve with technology we treat innovation as a way of life, a life we dedicate to improvement and advancement of Safety, Health and Environment.